Alzheimer Dementia

Neurology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

DS
Daiichi SankyoChina - Shanghai
1 program
Standard therapy of Alzheimer DementiaN/A1 trial
Active Trials
NCT02267486Completed972

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Daiichi SankyoStandard therapy of Alzheimer Dementia

Clinical Trials (1)

Total enrollment: 972 patients across 1 trials

NCT02267486Daiichi SankyoStandard therapy of Alzheimer Dementia

Exploratory Study for the Validity of QuQu Scale

Start: Oct 2014972 patients
N/ACompleted

Related Jobs in Neurology

Specialty Account Manager, Symbravo (Queens, NY)

Axsome Therapeutics
Queens, NY
Yesterday
$100K - $150K/yr

Specialist Quality Services (Product Complaints)

Sanofi
Hyderabad
Yesterday

Digital Product Lead - iCare Connect

Sanofi
Cambridge, MA
Yesterday
$134K - $193K/yr

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
2d ago
$208K - $234K/yr

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
2d ago

Electronics Engineering Manager

CoMind
London, UK
2d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Epilepsy(299)Multiple Sclerosis(285)Schizophrenia(268)Parkinson Disease(187)Alzheimer's Disease(183)Parkinson's Disease(166)Alzheimer Disease(120)Stroke(104)Migraine(85)Depression(84)